ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,702.55
-0.19%
US Tech 100
19,290.40
-0.04%
Dow Jones
42,063.36
0.09%
Brent Oil
73.925
0.05%
Bitcoin
63,551.49
-0.11%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Astrazeneca Plc (AZN) Quote

Astrazeneca Plc

Astrazeneca Plc (AZN)

AstraZeneca PLC
AZN Capital Corp
11,652.00
-128.00
( -1.09% )
Updated: 05:02:23
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
11,652.00
Bid
11,650.00
Ask
11,654.00
Volume
219,807
11,622.00 Day's Range 11,738.00
9,461.00 52 Week Range 13,338.00
Market Cap
180.639B
Previous Close
11,780.00
Open
11,680.00
Last Trade
27
@
11652
(AT)
Last Trade Time
05:02:17
Financial Volume
25,664,380p
VWAP
11,675.87
Average Volume (3m)
1,671,329
Shares Outstanding
1,550,286,637
Dividend Yield
2.00%
PE Ratio
30.33
Earnings Per Share (EPS)
3.84
Revenue
45.81B
Net Profit
5.96B

About Astrazeneca Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.astrazeneca.com
Headquarters
Cambridge, Gbr
Founded
-
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 11,780p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 13,338.00p.

Astrazeneca currently has 1,550,286,637 shares outstanding. The market capitalization of Astrazeneca is £182.62 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 30.33.

Ask ADVFN Intelligence (AI)

AZN Latest News

More News

TOP NEWS: AstraZeneca cancer drug fails to significantly extend lives

AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow thi ...

2 hours ago
Alliance News

AstraZeneca PLC Fasenra recommended for EU approval in EGPA

AstraZeneca PLC 23 September 2024   23 September 2024 Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis   New indication...

3 hours ago
RNS Regulatory News

AstraZeneca PLC Final OS results reported for TROPION-Breast01

AstraZeneca PLC 23 September 2024     23 September 2024   Datopotamab deruxtecan final overall survival results reported in patients with metastatic HR-positive, HER2-low or negative breast...

3 hours ago
RNS Regulatory News

AstraZeneca gets FDA approval for FluMist self-administration

AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in t ...

September 20 2024
Alliance News

AstraZeneca PLC FluMist approved for self-administration in US

AstraZeneca PLC 20 September 2024     20 September 2024   FluMist approved for self-administration in the US   Only influenza vaccine approved for self- or caregiver-administration at home...

September 20 2024
RNS Regulatory News

AstraZeneca PLC Fasenra EGPA US FDA approval

AstraZeneca PLC 18 September 2024     18 September 2024 Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis New indication supported by the MANDARA trial which showed...

September 18 2024
RNS Regulatory News

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, September 24 and Wednesday...

September 17 2024
GlobeNewswire Inc.

TOP NEWS: AstraZeneca celebrates survival rate of Imfinzi-Imjudo mix

AstraZeneca PLC on Monday said that Imfinzi plus Imjudo showed a clinically meaningful overall survival benefit for p ...

September 16 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-348-2.9120001211011600235432211880.047112DE
4-1496-11.3781563736131481333811600201062612491.2836579DE
12-716-5.78913324709123681333811540167132912484.6004751DE
26121811.6733755032104341333810314187864112123.2172902DE
525144.614832106311138133389461212356311130.594232DE
156299834.64293968118654133388091213278610566.4086158DE
260438960.429574556726313338587122543089372.54573502DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GBPGlobal Petroleum Limited
0.165p
(32.00%)
442.63M
MOSMobile Streams Plc
0.175p
(18.64%)
63.86M
CEGChallenger Energy Group Plc
7.00p
(14.75%)
727.64k
WCATWildcat Petroleum Plc
0.24p
(14.29%)
26.07M
SVMLSovereign Metals Limited
36.50p
(12.31%)
297.84k
FCMFirst Class Metals Plc
1.75p
(-38.60%)
4.82M
BLVNBowleven Plc
0.175p
(-36.36%)
1.88M
DISDistil Plc
0.145p
(-27.50%)
1.34M
AWEAlphawave Ip Group Plc
91.20p
(-27.04%)
3.39M
VASTVast Resources Plc
0.075p
(-26.83%)
44.04M
GBPGlobal Petroleum Limited
0.165p
(32.00%)
442.63M
DKEDukemount Capital Plc
0.031p
(5.08%)
194.48M
MSMNMosman Oil And Gas Limited
0.0355p
(1.43%)
185.93M
UKOGUk Oil & Gas Plc
0.0405p
(-1.22%)
138.39M
MOSMobile Streams Plc
0.175p
(18.64%)
63.86M

Discussion

View Full Feed
easymoney easymoney 5 minutes ago
All is great as I'm back in thailand after a month in Laos.
LVerstee LVerstee 5 minutes ago
I hate fiction. Let's stay with facts. The fact for instance that Laxmi is again delating as much as he can. First writes a very long email outlining his empty promises, then goes silent again.

https://investorshub.advfn.com/uimage/uploads/2024/9/23/ikmwgLaxmi_no_responses.png
ITUP
reena969 reena969 7 minutes ago
NUKK RSI is at 17+, and it looks like the lower Bollinger Band support has been broken. We might see lower lows until around 6am
NUKK
TalShu TalShu 10 minutes ago
Does the following remind Blue voters of a Sarissa proxy-war promise?

Financial Times

NHS lunches 'suscription' scheme for antibiotics with Pharma sector.

Drugmakers will Receive flat fies for new medicines in push to avoide overuse.

By Ian
AMRN
TIMGZ TIMGZ 13 minutes ago
NO, NOT YET. AS U EXPRESSED***MIGHT BE 7AM RUN. I WANT TO SLEEP MORE
reena969 reena969 13 minutes ago
NUKK RSI, 28+ looking good 11.2 mil volume
NUKK
CarlCarlMcB CarlCarlMcB 14 minutes ago
Merry Christmas $$$$$$)))
AGRI
Wayne R Wayne R 15 minutes ago
When the forward split is implemented it would put the stock price a bit too close to the minimum $1.00 price threshold.

The stock would need to rally otherwise a reverse split is inevitable.
AGBA
CarlCarlMcB CarlCarlMcB 15 minutes ago
Harpoon!!!!!! Enjoy the ride $$$))))))))))
AGRI
reena969 reena969 16 minutes ago
NUKK is approaching support with 10 million in volume, trading sideways—showing solid accumulation so far
NUKK
scotty3371 scotty3371 19 minutes ago
Wow. Thanks flipper.
NWBO
Swammmie1040 Swammmie1040 20 minutes ago
Its in the quarterly report approx $270,000 (outstanding balance)
https://www.otcmarkets.com/otcapi/company/financial-report/409989/content
Scroll down to convertable notes page 5 B
SINC
reena969 reena969 20 minutes ago
LGCB just crossed under support , wait for second conformation candle
Wayne R Wayne R 20 minutes ago
Don't worry, it'll probably be delayed enough for Davie boyo to cash in his incentive shares.

JMO
MULN
reena969 reena969 27 minutes ago
TIMGZ are you back in NUKK?
NUKK
Investor2014 Investor2014 28 minutes ago
See bits in bold.

Given in the Blum and Huey complaint and then consolidated complaint are not doing a good job of:
A PSLRA plaintiff must allege facts demonstrating the existence of the following elements to be entitled to discovery: “(1) a material misrepresentation (or omiss
AVXL
reena969 reena969 30 minutes ago
LGCG RSI 70+
reena969 reena969 32 minutes ago
LGCG using middle Bollinger band as support, so far
reena969 reena969 33 minutes ago
NUKK .293 entry, 4.01:05
.448 exit 4:02:15 Fast enough for you? $$$$$
NUKK
luvwetscent luvwetscent 36 minutes ago
"soon" with Elite is measured in years
ELTP
fritz603 fritz603 37 minutes ago
page 40: if there is an ECAPS Outcome, PLC shall pay the Tier Z Distributions in the
following proportions:
(A) 42% to GP1; and
(B) 58% to LBHI;
(ii) if there is an LBHI Outcome, PLC shall pay the Tier Z Distributions in the
following proportions:
(A) 12% to
LEHNQ
reena969 reena969 37 minutes ago
Exactly right, NUKK could be the 7am runner. Keep an eye on it—lower Bollinger Band entry expected in about an hour. They need to accumulate first, but volume looks healthy
NUKK
fritz603 fritz603 41 minutes ago
https://www.rns-pdf.londonstockexchange.com/rns/8664E_1-2024-9-19.pdf
page 39: if there is an ECAPS Outcome, PLC shall pay the Tier Y Distributions in
the following proportions:
(A) 94% to GP1; and
(B) 6% to LBHI
LEHNQ
reena969 reena969 41 minutes ago
They are not TRAPS, they are QUICK SCALPS. I've been missing out on this quick money for a while
TIMGZ TIMGZ 44 minutes ago
SOM ANY TRAP THIS MORNING, BE CAREFUL*** ON THE SIDE LINE

Your Recent History

LSE
AZN
Astrazeneca
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved